Logo image of CTZ.CA

NAMSYS INC (CTZ.CA) Stock Fundamental Analysis

Canada - TSX-V:CTZ - CA6300001071 - Common Stock

1.59 CAD
+0.04 (+2.58%)
Last: 9/12/2025, 7:00:00 PM
Fundamental Rating

7

CTZ gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 63 industry peers in the Software industry. Both the health and profitability get an excellent rating, making CTZ a very profitable company, without any liquidiy or solvency issues. CTZ is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year CTZ was profitable.
In the past year CTZ had a positive cash flow from operations.
CTZ had positive earnings in 4 of the past 5 years.
Of the past 5 years CTZ 4 years had a positive operating cash flow.
CTZ.CA Yearly Net Income VS EBIT VS OCF VS FCFCTZ.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M 2M

1.2 Ratios

The Return On Assets of CTZ (22.25%) is better than 93.65% of its industry peers.
CTZ has a better Return On Equity (25.13%) than 90.48% of its industry peers.
CTZ has a better Return On Invested Capital (22.46%) than 93.65% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CTZ is significantly above the industry average of 12.19%.
The 3 year average ROIC (20.76%) for CTZ is below the current ROIC(22.46%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 22.25%
ROE 25.13%
ROIC 22.47%
ROA(3y)20.74%
ROA(5y)14.37%
ROE(3y)23.07%
ROE(5y)12.84%
ROIC(3y)20.76%
ROIC(5y)24%
CTZ.CA Yearly ROA, ROE, ROICCTZ.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150 200 250

1.3 Margins

The Profit Margin of CTZ (31.81%) is better than 96.83% of its industry peers.
In the last couple of years the Profit Margin of CTZ has remained more or less at the same level.
CTZ's Operating Margin of 39.85% is amongst the best of the industry. CTZ outperforms 98.41% of its industry peers.
In the last couple of years the Operating Margin of CTZ has declined.
The Gross Margin of CTZ (64.32%) is better than 71.43% of its industry peers.
In the last couple of years the Gross Margin of CTZ has remained more or less at the same level.
Industry RankSector Rank
OM 39.85%
PM (TTM) 31.81%
GM 64.32%
OM growth 3Y0.73%
OM growth 5Y-2.15%
PM growth 3Y6.28%
PM growth 5Y-0.63%
GM growth 3Y1.23%
GM growth 5Y-1.35%
CTZ.CA Yearly Profit, Operating, Gross MarginsCTZ.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

10

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CTZ is creating value.
CTZ has less shares outstanding than it did 1 year ago.
CTZ has less shares outstanding than it did 5 years ago.
CTZ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CTZ.CA Yearly Shares OutstandingCTZ.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CTZ.CA Yearly Total Debt VS Total AssetsCTZ.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

CTZ has an Altman-Z score of 23.97. This indicates that CTZ is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 23.97, CTZ belongs to the top of the industry, outperforming 95.24% of the companies in the same industry.
CTZ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 23.97
ROIC/WACC2.11
WACC10.64%
CTZ.CA Yearly LT Debt VS Equity VS FCFCTZ.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M

2.3 Liquidity

CTZ has a Current Ratio of 8.67. This indicates that CTZ is financially healthy and has no problem in meeting its short term obligations.
CTZ's Current ratio of 8.67 is amongst the best of the industry. CTZ outperforms 92.06% of its industry peers.
A Quick Ratio of 8.67 indicates that CTZ has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 8.67, CTZ belongs to the best of the industry, outperforming 92.06% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.67
Quick Ratio 8.67
CTZ.CA Yearly Current Assets VS Current LiabilitesCTZ.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 36.62% over the past year.
Measured over the past years, CTZ shows a quite strong growth in Earnings Per Share. The EPS has been growing by 9.78% on average per year.
Looking at the last year, CTZ shows a quite strong growth in Revenue. The Revenue has grown by 19.40% in the last year.
Measured over the past years, CTZ shows a quite strong growth in Revenue. The Revenue has been growing by 10.68% on average per year.
EPS 1Y (TTM)36.62%
EPS 3Y17.83%
EPS 5Y9.78%
EPS Q2Q%6.84%
Revenue 1Y (TTM)19.4%
Revenue growth 3Y11.2%
Revenue growth 5Y10.68%
Sales Q2Q%21.06%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CTZ.CA Yearly Revenue VS EstimatesCTZ.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 17.67, the valuation of CTZ can be described as rather expensive.
CTZ's Price/Earnings ratio is rather cheap when compared to the industry. CTZ is cheaper than 85.71% of the companies in the same industry.
When comparing the Price/Earnings ratio of CTZ to the average of the S&P500 Index (27.30), we can say CTZ is valued slightly cheaper.
Industry RankSector Rank
PE 17.67
Fwd PE N/A
CTZ.CA Price Earnings VS Forward Price EarningsCTZ.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CTZ is valued cheaply inside the industry as 82.54% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CTZ indicates a rather cheap valuation: CTZ is cheaper than 80.95% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 18.68
EV/EBITDA 8.37
CTZ.CA Per share dataCTZ.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.1 0.2 0.3

4.3 Compensation for Growth

The excellent profitability rating of CTZ may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.81
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CTZ!.
Industry RankSector Rank
Dividend Yield N/A

NAMSYS INC

TSX-V:CTZ (9/12/2025, 7:00:00 PM)

1.59

+0.04 (+2.58%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)06-26 2025-06-26
Earnings (Next)09-30 2025-09-30
Inst Owners21.38%
Inst Owner ChangeN/A
Ins Owners8.18%
Ins Owner ChangeN/A
Market Cap42.80M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.05
Dividend Growth(5Y)N/A
DP56.26%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 17.67
Fwd PE N/A
P/S 5.67
P/FCF 18.68
P/OCF 18.61
P/B 4.48
P/tB 4.48
EV/EBITDA 8.37
EPS(TTM)0.09
EY5.66%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.09
FCFY5.35%
OCF(TTM)0.09
OCFY5.37%
SpS0.28
BVpS0.35
TBVpS0.35
PEG (NY)N/A
PEG (5Y)1.81
Profitability
Industry RankSector Rank
ROA 22.25%
ROE 25.13%
ROCE 31.49%
ROIC 22.47%
ROICexc 502.09%
ROICexgc 502.09%
OM 39.85%
PM (TTM) 31.81%
GM 64.32%
FCFM 30.36%
ROA(3y)20.74%
ROA(5y)14.37%
ROE(3y)23.07%
ROE(5y)12.84%
ROIC(3y)20.76%
ROIC(5y)24%
ROICexc(3y)454.3%
ROICexc(5y)N/A
ROICexgc(3y)454.3%
ROICexgc(5y)N/A
ROCE(3y)29.1%
ROCE(5y)33.64%
ROICexcg growth 3Y-15.99%
ROICexcg growth 5Y13.62%
ROICexc growth 3Y-15.99%
ROICexc growth 5Y13.62%
OM growth 3Y0.73%
OM growth 5Y-2.15%
PM growth 3Y6.28%
PM growth 5Y-0.63%
GM growth 3Y1.23%
GM growth 5Y-1.35%
F-Score7
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 125%
Cap/Sales 0.12%
Interest Coverage 250
Cash Conversion 76.29%
Profit Quality 95.44%
Current Ratio 8.67
Quick Ratio 8.67
Altman-Z 23.97
F-Score7
WACC10.64%
ROIC/WACC2.11
Cap/Depr(3y)76.27%
Cap/Depr(5y)51.64%
Cap/Sales(3y)0.13%
Cap/Sales(5y)0.16%
Profit Quality(3y)96.79%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.62%
EPS 3Y17.83%
EPS 5Y9.78%
EPS Q2Q%6.84%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)19.4%
Revenue growth 3Y11.2%
Revenue growth 5Y10.68%
Sales Q2Q%21.06%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y35.72%
EBIT growth 3Y12.01%
EBIT growth 5Y8.3%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y48.59%
FCF growth 3YN/A
FCF growth 5Y12.45%
OCF growth 1Y48.62%
OCF growth 3YN/A
OCF growth 5Y12.31%